InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+7.5%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Pieper Steven, Chief Financial Officer. Director active across 2 companies, notably Xeris Pharmaceuticals INC. Aggregated, 17 disclosures have been logged. Breakdown: 2 buys · 3 sells. Total volume traded: €465k. Activity tracked since 28 July 2021. The latest transaction was disclosed on 12 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Pieper Steven
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
5,000 shares@ US$8.500.0029% mcap3.4% of flowCommon StockSEC:0001875714-26-000009:0
17,400 shares@ US$8.500.010% mcap13.0% of flowCommon StockSEC:0001875714-26-000007:0
27,600 shares@ US$8.52450.016% mcap20.6% of flowCommon StockSEC:0001875714-26-000007:1
27,891 shares@ US$4.099.3% of flowCommon StockSEC:0001875714-26-000004:0
154,986 shares0Common StockSEC:0001875714-26-000002:0
110,750 shares@ US$3.5657.2% of flowCommon StockSEC:0001867096-25-000024:0
32,059 shares@ US$3.6117.0% of flowCommon StockSEC:0001867096-25-000012:0
19,483 shares@ US$1.554.3% of flowCommon StockSEC:0001867096-24-000190:0
3,460 shares@ US$2.111.0% of flowCommon StockSEC:0001867096-24-000168:0
450,000 shares0Common StockSEC:0001867096-24-000018:0
28,000 shares@ US$1.957.5% of flowCommon StockSEC:0001867096-23-000149:0
Canonical exit: 18 Feb 2024 (T+90)
750,000 shares0Common StockSEC:0001867096-23-000022:0
200,000 shares0Common StockSEC:0001867096-22-000012:0
25,000 shares@ US$1.99674.1% of flowCommon StockSEC:0001867096-21-000075:0
Canonical exit: 8 Feb 2022 (T+90)
23,775 sharesCommon StockSEC:0000899243-21-039324:0
23,775 sharesCommon StockSEC:0000899243-21-039253:0
100,000 shares0Common StockSEC:0000899243-21-030664:0
17 of 17 declarations
About Pieper Steven
Pieper Steven is Directeur Financier at Xeris Pharmaceuticals INC and appears in 16 filings. Across the 16 sampled filings, the reported totals are EUR 93108 in buys and EUR 334870 in sells, with filings dated from 2021-07-29 to 2026-07-07, and the most frequent transaction nature is Attribution.
